Published by Iain Gilbert on 13th August 2024
(Sharecast News) - Analysts at Berenberg raised their target price on Hikma Pharmaceuticals from 2,000.0p to 2,100.0p on Tuesday following an "impressive" H1 performance.
URL: http://www.digitallook.com/dl/news/story/34488504/...